Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO screening trial: A nested case-control study

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Weinstein, Stephanie J ^a   Peters, Ulrike ^b,c   Ahn, Jiyoung ^d   Friesen, Marlin D ^e   Riboli, Elio ^f   Hayes, Richard B ^d   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROSTATE CANCER; RISK ASSESSMENT;

AGED; ALPHA-TOCOPHEROL; CASE-CONTROL STUDIES; GAMMA-TOCOPHEROL; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK;

EID: 84863613112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040204     Document Type: Article

References (63)

1. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, et al. (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90: 440-446.
2. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301: 39-51.
3. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia M, et al. (2011) Vitamin E and the Risk of Prostate Cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306: 1549-1556.
4. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, et al. (2009) Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 301: 52-62.
5. Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, et al. (1999) Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 8: 893-899.
6. Eichholzer M, Stahelin HB, Gey KF, Ludin E, Bernasconi F, (1996) Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 66: 145-150.
7. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, et al. (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59: 1225-1230.
8. Goodman GE, Schaffer S, Omenn GS, Chen C, King I, (2003) The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 12: 518-526.
9. Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, et al. (2005) Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 97: 396-399.
10. Weinstein SJ, Wright ME, Lawson KA, Snyder K, Mannisto S, et al. (2007) Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16: 1253-1259.
11. Watters JL, Gail MH, Weinstein SJ, Virtamo J, Albanes D, (2009) Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res 69: 3833-3841.
12. Rodriguez C, Jacobs EJ, Mondul AM, Calle EE, McCullough ML, et al. (2004) Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 13: 378-382.
13. Cheng T, Barnett MJ, Kristal AE, Ambrosone CB, King IB, et al. (2011) Genetic variation in myeloperoxidase modifies the association of serum alpha-tocopherol with aggressive prostate cancer among current smokers. J Nutr 141: 1731-1737.
14. Fleshner NE, (2002) Vitamin E and prostate cancer. Urol Clin North Am 29: 107-13, ix.
15. Ricciarelli R, Zingg JM, Azzi A, (2001) Vitamin E: protective role of a Janus molecule. FASEB J 15: 2314-2325.
16. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, et al. (2002) The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76: 703-716.
17. Venkateswaran V, Klotz LH, (2010) Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 7: 442-453.
18. Traber MG, (1999) Vitamin E. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern Nutrition in Health and Disease. Baltimore, MD: Lippincott Williams & Wilkins pp. 347-362.
19. Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, et al. (2000) Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 152: 279-286.
20. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, et al. (2000) Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21: 349S-355S.
21. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, et al. (2007) Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 16: 962-968.
22. Fleming ID, Cooper JS, Henson ED, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW, (1997) AJCC Cancer Staging Manual, 5th edition. Philadelphia: Lippincot-Raven.
23. Rothman K, Greenland S, (1998) Modern Epidemiology. Philadelphia: Lippincott Raven.
24. Steghens JP, van Kappel AL, Riboli E, Collombel C, (1997) Simultaneous measurement of seven carotenoids, retinol and alpha-tocopherol in serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 694: 71-81.
25. The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4: 1-10.
26. Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, et al. (2006) Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 98: 245-254.
27. Peters U, Littman AJ, Kristal AR, Patterson RE, Potter JD, et al. (2008) Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control 19: 75-87.
28. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, et al. (2007) Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 86: 672-681.
29. Gill JK, Franke AA, Steven MJ, Cooney RV, Wilkens LR, et al. (2009) Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control 20: 1161-1171.
30. Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BE, et al. (2006) Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study (United States). Cancer Causes Control 17: 1193-1207.
31. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, et al. (2003) Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 157: 335-344.
32. Wright ME, Weinstein SJ, Lawson KA, Albanes D, Subar AF, et al. (2007) Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 16: 1128-1135.
33. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, et al. (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92: 2018-2023.
34. Nomura AM, Stemmermann GN, Lee J, Craft NE, (1997) Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6: 487-491.
35. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, et al. (1988) Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol 127: 28-41.
36. Hayes RB, Bogdanovicz JF, Schroeder FH, De Bruijn A, Raatgever JW, et al. (1988) Serum retinol and prostate cancer. Cancer 62: 2021-2026.
37. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S, (2006) Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr 84: 375-383.
38. Wagner KH, Kamal-Eldin A, Elmadfa I, (2004) Gamma-Tocopherol- An Underestimated Vitamin? Ann Nutr Metab 48: 169-188.
39. Huang HY, Appel LJ, (2003) Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 133: 3137-3140.
40. Handelman GJ, Machlin LJ, Fitch K, Weiter JJ, Dratz EA, (1985) Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr 115: 807-813.
41. Jiang Q, Christen S, Shigenaga MK, Ames BN, (2001) Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 74: 714-722.
42. Saldeen K, Saldeen T, (2005) Importance of tocopherols beyond alpha-tocopherol: evidence from animal and human studies. Nutrition Research 25: 877-889.
43. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330: 1029-1035.
44. Meyer F, Galan P, Douville P, Bairati I, Kegle P, et al. (2005) Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 116: 182-186.
45. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, et al. (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293: 1338-1347.
46. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 23-33.
47. Gann PH, (2009) Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance-next, cause. JAMA 301: 102-103.
48. Bruno RS, Traber MG, (2005) Cigarette smoke alters human vitamin E requirements. J Nutr 135: 671-674.
49. Bruno RS, Ramakrishnan R, Montine TJ, Bray TM, Traber MG, (2005) Alpha-tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. Am J Clin Nutr 81: 95-103.
50. Zhang Y, Ni J, Messing EM, Chang E, Yang CR, et al. (2002) Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci U S A 99: 7408-7413.
51. Ni J, Chen M, Zhang Y, Li R, Huang J, et al. (2003) Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery. Biochem Biophys Res Commun 300: 357-363.
52. Mondul AM, Rohrmann S, Menke A, Feinleib M, Nelson WG, et al. (2011) Association of serum alpha-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk. Cancer Causes Control 22: 827-836.
53. Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, et al. (2001) Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. Prostate 46: 33-38.
54. Woodson K, Triantos S, Hartman T, Taylor PR, Virtamo J, et al. (2002) Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. Anticancer Res 22: 375-378.
55. Mondul AM, Rager HC, Kopp W, Virtamo J, Albanes D, (2011) Supplementation with alpha-tocopherol or beta-carotene reduces serum concentrations of vascular endothelial growth factor-D, but Not-A or-C, in male smokers. J Nutr 141: 2030-2034.
56. Rossini A, de Almeida ST, Albano RM, Pinto LF, (2008) CYP2A6 polymorphisms and risk for tobacco-related cancers. Pharmacogenomics 9: 1737-1752.
57. Traber MG, (2010) Regulation of xenobiotic metabolism, the only signaling function of alpha-tocopherol? Mol Nutr Food Res 54: 661-668.
58. Parker RS, Sontag TJ, Swanson JE, McCormick CC, (2004) Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism. Ann N Y Acad Sci 1031: 13-21.
59. Sontag TJ, Parker RS, (2002) Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 277: 25290-25296.
60. Major JM, Yu K, Wheeler W, Zhang H, Cornelis MC, et al. (2011) Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum Mol Genet.
61. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN, (2000) gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 97: 11494-11499.
62. Moyad MA, Brumfield SK, Pienta KJ, (1999) Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol 17: 85-90.
63. Comstock GW, Burke AE, Hoffman SC, Norkus EP, Gross M, et al. (2001) The repeatability of serum carotenoid, retinoid, and tocopherol concentrations in specimens of blood collected 15 years apart. Cancer Epidemiol Biomarkers Prev 10: 65-68.